Use of Cuvitru® in children with PID - Ep. 1

 

Nursing specialist Myriam Osswald explains how our subcutaneous immunoglobulin Cuvitru® is used in children with primary immunodeficiency and how the affected families can live a less complicated everyday life through self-administration despite the drastic diagnosis.

 

Moderator: Dr. med. Marcus Kühn, Specialist in Allergology and clinical Immunology at the Löwenpraxis Lucerne      (website).

 

Guest: Myriam Osswald, Nursing Specialist at Careformance (website).

 

Resources and Links:


[1] Krivan G, Jolles S, Granados EL, Paolantonacci P, Ouaja R, Cissé OA, Bernatowska E. New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients. Am J Clin Exp Immunol. 2017 Nov 1;6(5):76-83. PMID: 29181272; PMCID: PMC5698561.

[2] Devonshire AL, Makhija M. Approach to primary immunodeficiency. Allergy Asthma Proc. 2019 Nov 1;40(6):465-469. doi: 10.2500/aap.2019.40.4273. PMID: 31690396.

Cuvitru®prescribing information; www.swissmedicinfo.ch

Healthcare professionals may request a complete copy of the cited literature from the pharmaceutical company.

C-APROM/CH/CUVI/0100_11/2023